William M. Canfield
Director Ejecutivo en Siwa Biotech Corp. .
Perfil
William M.
Canfield is the founder and currently serves as the Chairman & Chief Executive Officer of Siwa Biotech Corp., which he founded in 2005.
He also previously served as Co-Chairman at Cytovance Biologics, Inc.
Cargos activos de William M. Canfield
| Empresas | Cargo | Inicio |
|---|---|---|
Siwa Biotech Corp.
 Siwa Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Siwa Biotech Corp. develops a technology for the development of male non-hormonal contraceptive pill. It develops tyrosylprotein sulfotransferase (TPST) inhibitors to be used as a male contraceptive with anti-HIV activity. The company was founded by William M. Canfield and Kevin L. Moore in 2005 and is headquartered in Oklahoma City, OK. | Director Ejecutivo | 01/01/2005 |
Antiguos cargos conocidos de William M. Canfield.
| Empresas | Cargo | Fin |
|---|---|---|
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Presidente | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Siwa Biotech Corp.
Siwa Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Siwa Biotech Corp. develops a technology for the development of male non-hormonal contraceptive pill. It develops tyrosylprotein sulfotransferase (TPST) inhibitors to be used as a male contraceptive with anti-HIV activity. The company was founded by William M. Canfield and Kevin L. Moore in 2005 and is headquartered in Oklahoma City, OK. | Commercial Services |
- Bolsa de valores
- Insiders
- William M. Canfield
